JUN 10, 2021 8:00 AM PDT

Algorithm Flags High Risk of Pancreatic Cancer

WRITTEN BY: Tara Fernandez

In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to machine learning (ML) to help identify those most at risk of developing the disease, such that they can access early interventions.

In the study, published in PLOS ONE, researchers describe how they analyzed health records from over 1,000 patients in the UK, up to two years before their pancreatic cancer diagnosis. They used this data to train an ML algorithm to distinguish patients at risk.

The ML system found 41 percent of the patients to be in the high-risk category, up to 20 months before they receive the diagnosis. The test had a 72 percent sensitivity, meaning the ability to successfully identify those who went on to develop pancreatic cancer. 59 percent of people who did not end up getting pancreatic cancer were categorized as low risk by the algorithm. The specificity and sensitivity of the system can be refined and improved with additional work, say the authors.

"Each year, 460,000 people worldwide are diagnosed with pancreatic cancer, and only around 5% of those diagnosed survive for five years or more,” explained co-lead author Ananya Malhotra. “This low survival is because patients are usually diagnosed very late. Recent progress has been made in identifying biomarkers in the blood and urine, but these tests cannot be used for population screening as they would be very expensive and potentially harmful due to the psychological distress of excess testing.

"Although preliminary, this study offers some hope for a new early diagnosis for pancreatic cancer which until now remains elusive."

 



Sources: PLOS One, EurekAlert.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
APR 29, 2021
Clinical & Molecular DX
We've Now Collected Over 1 Million Coronavirus Sequences
APR 29, 2021
We've Now Collected Over 1 Million Coronavirus Sequences
Over 1.2 million genome sequences collected from 172 countries have been uploaded to a data-sharing site over the course ...
MAY 13, 2021
Clinical & Molecular DX
Smart Patch Measures How Itchy You Are
MAY 13, 2021
Smart Patch Measures How Itchy You Are
A wearable “scratch sensor” developed by researchers at Northwestern University could finally help doctors m ...
MAY 09, 2021
Genetics & Genomics
Another Neurodevelopmental Disorder is Discovered
MAY 09, 2021
Another Neurodevelopmental Disorder is Discovered
Researchers are identifying more rare disorders because of advances in genetic sequencing technologies, which have made ...
JUN 07, 2021
Clinical & Molecular DX
COVID Test Results in a Second?
JUN 07, 2021
COVID Test Results in a Second?
Scientists have developed a handheld diagnostic device, capable of detecting the presence of the SARS-CoV-2’s spik ...
JUN 24, 2021
Clinical & Molecular DX
Test Lets Cancer Patients Track Whether Their Treatment Is Working in Real Time
JUN 24, 2021
Test Lets Cancer Patients Track Whether Their Treatment Is Working in Real Time
Researchers from Singapore have created the ExoSCOPE, the world’s first blood test for tracking whether or not a p ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
Loading Comments...